. Show Affiliations »
Abstract
Mesh: See more » Administration, OralAminopterin/analogs & derivativesAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsBevacizumabCetuximabDepsipeptidesDrug ApprovalEverolimusFerrosoferric OxideGlutamatesGuanine/analogs & derivativesHumansInjectionsPanitumumabPemetrexedPyrimidinesSirolimus/analogs & derivativesSulfonamidesUnited StatesUnited States Food and Drug Administration
Substances: See more » 10-propargyl-10-deazaaminopterinAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsDepsipeptidesGlutamatesPyrimidinesSulfonamidesPemetrexedBevacizumabGuaninePanitumumabpazopanibEverolimusromidepsinAminopterinofatumumabCetuximabSirolimusFerrosoferric Oxide
Year: 2010 PMID: 20145211 DOI: 10.1093/jnci/djq030
Source DB: PubMed Journal: J Natl Cancer Inst ISSN: 0027-8874 Impact factor: 13.506